Karen Hoffman Lent and Kenneth Schwartz
For this month’s column, we virtually sat down with FTC Commissioner Christine Wilson for a conversation in which she offered her thoughts on a wide array of topics, ranging from the proposed merger moratorium and price-gouging legislation to the recent AbbVie/Allergan consent agreement and beyond. Below are excerpts from the interview.
Ken Schwartz: Commissioner, thanks so much for taking the time to join us this morning. We really appreciate it.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
